CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 48 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 4.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,495,904 | +4.5% | 694,885 | +0.0% | 0.00% | 0.0% |
| Q2 2023 | $4,301,197 | +117.9% | 694,862 | +35.2% | 0.00% | +50.0% |
| Q1 2023 | $1,973,516 | +23.8% | 514,116 | -0.1% | 0.00% | +100.0% |
| Q4 2022 | $1,594,726 | -23.1% | 514,428 | -0.3% | 0.00% | -50.0% |
| Q3 2022 | $2,073,000 | -17.8% | 515,746 | -0.4% | 0.00% | 0.0% |
| Q2 2022 | $2,521,000 | -45.7% | 517,577 | +0.1% | 0.00% | -33.3% |
| Q1 2022 | $4,639,000 | -20.3% | 517,235 | +0.0% | 0.00% | -25.0% |
| Q4 2021 | $5,823,000 | -5.8% | 517,123 | +39.7% | 0.00% | 0.0% |
| Q3 2021 | $6,184,000 | -25.1% | 370,292 | -0.3% | 0.00% | -33.3% |
| Q2 2021 | $8,251,000 | – | 371,504 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Index Venture Life Associates VI Ltd | 9,961,789 | $112,170,000 | 100.00% |
| Medicxi Ventures Management (Jersey) Ltd | 18,123,892 | $204,075,000 | 51.07% |
| Vida Ventures Advisors, LLC | 3,931,818 | $44,272,000 | 16.56% |
| OUP Management Co., LLC | 2,341,891 | $26,370,000 | 11.89% |
| Samsara BioCapital, LLC | 1,459,693 | $16,436,000 | 3.19% |
| VR Adviser, LLC | 1,127,272 | $12,693,000 | 1.74% |
| Affinity Asset Advisors, LLC | 419,144 | $4,720,000 | 1.71% |
| Cormorant Asset Management, LP | 2,489,894 | $28,036,000 | 1.67% |
| Kynam Capital Management, LP | 239,041 | $2,692,000 | 1.44% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $109,017,000 | 0.84% |